{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T21:22:42Z","timestamp":1773523362803,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,28]]},"DOI":"10.7759\/cureus.98001","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:56:33Z","timestamp":1764330993000},"source":"Crossref","is-referenced-by-count":1,"title":["Successful Management of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema With Tranexamic Acid: A Case Report"],"prefix":"10.7759","author":[{"given":"Mussab","family":"Ibrahem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Prescriptions dispensed in the community. (2025). Accessed. November 28, 2025: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/prescriptions-dispensed-in-the-community."},{"key":"ref2","article-title":"Angiotensin-converting enzyme inhibitor-associated angioedema: incidence, risk factors, and management","volume":"98","author":"Brown NJ","year":"1996","unstructured":"Brown NJ, Vaughan DE, Murphey LJ, et al.. Angiotensin-converting enzyme inhibitor-associated angioedema: incidence, risk factors, and management. J Allergy Clin Immunol. 1996, 98:473-80.","journal-title":"J Allergy Clin Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.14.1637","article-title":"Incidence and characteristics of angioedema associated with enalapril","volume":"165","author":"Kostis JB","year":"2005","unstructured":"Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, Levy E. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005, 165:1637-42. 10.1001\/archinte.165.14.1637","journal-title":"Arch Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199818030-00003","article-title":"ACE inhibitor-induced angioedema. Incidence, prevention and management","volume":"18","author":"Vleeming W","year":"1998","unstructured":"Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf. 1998, 18:171-88. 10.2165\/00002018-199818030-00003","journal-title":"Drug Saf"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger J","year":"1998","unstructured":"Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet. 1998, 351:1693-7. 10.1016\/S0140-6736(97)09137-X","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12341","article-title":"A consensus parameter for the evaluation and management of angioedema in the emergency department","volume":"21","author":"Moellman JJ","year":"2014","unstructured":"Moellman JJ, Bernstein JA, Lindsell C, et al.. A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med. 2014, 21:469-84. 10.1111\/acem.12341","journal-title":"Acad Emerg Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2006.08.001","article-title":"Angiotensin-converting enzyme inhibitor-associated angioedema","volume":"26","author":"Byrd JB","year":"2006","unstructured":"Byrd JB, Adam A, Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am. 2006, 26:725-37. 10.1016\/j.iac.2006.08.001","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312524","article-title":"A randomized trial of icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Bas M","year":"2015","unstructured":"Bas M, Greve J, Stelter K, et al.. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015, 372:418-25. 10.1056\/NEJMoa1312524","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2017.04.001","article-title":"Pathogenesis of hereditary angioedema: the role of the bradykinin-forming cascade","volume":"37","author":"Kaplan AP","year":"2017","unstructured":"Kaplan AP, Joseph K. Pathogenesis of hereditary angioedema: the role of the bradykinin-forming cascade. Immunol Allergy Clin North Am. 2017, 37:513-25. 10.1016\/j.iac.2017.04.001","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2018.04.014","article-title":"[Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors]","volume":"39","author":"Beauch\u00eane C","year":"2018","unstructured":"Beauch\u00eane C, Martins-H\u00e9richer J, Denis D, Martin L, Maillard H. [Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors]. Rev Med Interne. 2018, 39:772-6. 10.1016\/j.revmed.2018.04.014","journal-title":"Rev Med Interne"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2012.10.008","article-title":"International consensus on hereditary and acquired angioedema","volume":"109","author":"Lang DM","year":"2012","unstructured":"Lang DM, Aberer W, Bernstein JA, et al.. International consensus on hereditary and acquired angioedema. Ann Allergy Asthma Immunol. 2012, 109:395-402. 10.1016\/j.anai.2012.10.008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2024.02.006","article-title":"Tranexamic acid for angiotensin converting enzyme inhibitor induced angioedema: a retrospective multicenter study","volume":"79","author":"Lindauer KE","year":"2024","unstructured":"Lindauer KE, Lo BM, Weingart GS, Karpov MV, Gartman GH, Neubauer LE, Kaplan MC. Tranexamic acid for angiotensin converting enzyme inhibitor induced angioedema: a retrospective multicenter study. Am J Emerg Med. 2024, 79:33-7. 10.1016\/j.ajem.2024.02.006","journal-title":"Am J Emerg Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur H","year":"2010","unstructured":"Shakur H, Roberts I, Bautista R, et al.. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010, 376:23-32. 10.1016\/S0140-6736(10)60835-5","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Shakur H","year":"2017","unstructured":"Shakur H, Roberts I, Fawole B, et al.. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017, 389:2105-16. 10.1016\/S0140-6736(17)30638-4","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/428633-successful-management-of-angiotensin-converting-enzyme-inhibitor-induced-angioedema-with-tranexamic-acid-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:56:36Z","timestamp":1764330996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/428633-successful-management-of-angiotensin-converting-enzyme-inhibitor-induced-angioedema-with-tranexamic-acid-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.98001","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}